GENEVA, July 2 -- SHENYANG SUNSHINE PHARMACEUTICAL CO., LTD. filed a patent application (CN2025/135305) for “NOVEL RECOMBINANT HUMAN THROMBOPOIETIN COMPOSITION”. With publication no. WO/2026/129974, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/85
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....